1. Anti-infection NF-κB Stem Cell/Wnt MAPK/ERK Pathway Apoptosis Metabolic Enzyme/Protease Immunology/Inflammation
  2. Bacterial NF-κB ERK Caspase Reactive Oxygen Species (ROS) Apoptosis
  3. N-3-oxo-dodecanoyl-L-homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone  (Synonyms: OdDHL; N-(3-オキソドデカノイル)-L-ホモセリンラクトン)

製品番号: HY-114544A 純度: 99.88%
COA 取扱説明書 Technical Support

N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) is a bacterial quorum-sensing signaling molecule produced by P. aeruginosa and strains of the B. cepacia complex.Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.N-3-oxo-dodecanoyl-L-Homoserine lactone induces the production of IL-8 in 16HBE human bronchial epithelial cells.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

N-3-oxo-dodecanoyl-L-homoserine lactone

N-3-oxo-dodecanoyl-L-homoserine lactone 構造式

CAS 番号 : 168982-69-2

容量 価格(税別) 在庫状況 数量
Solid + Solvent (Highly Recommended)
10 mM * 1 mL in DMSO
ready for reconstitution
USD 35 在庫あり
Solution
10 mM * 1 mL in DMSO USD 35 在庫あり
Solid
5 mg $32 在庫あり
10 mg $50 在庫あり
25 mg $115 在庫あり
50 mg $220 在庫あり
100 mg $390 在庫あり
200 mg   お問い合わせ  
500 mg   お問い合わせ  

* アイテムを追加する前、数量をご選択ください

This product is a controlled substance and not for sale in your territory.

カスタマーレビュー

Based on 2 publication(s) in Google Scholar

Top Publications Citing Use of Products
  • 生物活性

  • 純度とドキュメンテーション

  • 参考文献

  • カスタマーレビュー

製品説明

N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) is a bacterial quorum-sensing signaling molecule produced by P. aeruginosa and strains of the B. cepacia complex[1][2].Quorum sensing is a regulatory system used by bacteria for controlling gene expression in response to increasing cell density.N-3-oxo-dodecanoyl-L-Homoserine lactone induces the production of IL-8 in 16HBE human bronchial epithelial cells[3].

Cellular Effect
Cell Line Type Value Description References
DU-145 IC50
19.33 3
Compound: OdDHL
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
[PMID: 30553142]
DU-145 IC50
19.33 3
Compound: OdDHL
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
[PMID: 30553142]
EC9706 IC50
>128 3
Compound: OdDHL
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
[PMID: 25707012]
EC9706 IC50
> 128 3
Compound: OdDHL
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
[PMID: 25707012]
Jurkat EC50
250 3
Compound: 1, OdDHL
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
[PMID: 21488685]
Jurkat EC50
250 3
Compound: 1, OdDHL
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
[PMID: 21488685]
MCF7 IC50
26.24 3
Compound: OdDHL
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 30553142]
MCF7 IC50
26.24 3
Compound: OdDHL
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 30553142]
MCF7 IC50
37.31 3
Compound: OdDHL
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 25707012]
MCF7 IC50
37.31 3
Compound: OdDHL
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
101.83 3
Compound: OdDHL
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
29.53 3
Compound: OdDHL
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 30553142]
MGC-803 IC50
101.83 3
Compound: OdDHL
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
29.53 3
Compound: OdDHL
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 30553142]
NCI-H630 IC50
12 3
Compound: OdDHL
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
NCI-H630 IC50
12 3
Compound: OdDHL
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
NCI-H630 IC50
34 3
Compound: OdDHL
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
NCI-H630 IC50
34 3
Compound: OdDHL
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
PC-3 IC50
22.51 3
Compound: OdDHL
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
[PMID: 30553142]
DU-145 IC50
19.33 3
Compound: OdDHL
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
Antiproliferative activity against human DU145 cells after 72 hrs by MTT assay
[PMID: 30553142]
PC-3 IC50
22.51 3
Compound: OdDHL
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
[PMID: 30553142]
PC-3 IC50
5 3
Compound: OdDHL
Cytotoxicity against human PC3 cells after 5 days by SRB assay
Cytotoxicity against human PC3 cells after 5 days by SRB assay
[PMID: 19260689]
PC-3 IC50
5 3
Compound: OdDHL
Cytotoxicity against human PC3 cells after 5 days by SRB assay
Cytotoxicity against human PC3 cells after 5 days by SRB assay
[PMID: 19260689]
EC9706 IC50
> 128 3
Compound: OdDHL
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
Cytotoxicity against human EC9706 cells after 72 hrs by MTT assay
[PMID: 25707012]
SMMC-7721 IC50
> 128 3
Compound: OdDHL
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
[PMID: 25707012]
Jurkat EC50
250 3
Compound: 1, OdDHL
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
Cytotoxicity against human Jurkat E6-1 cells assessed as cell viability after 24 hrs by trypan blue exclusion assay
[PMID: 21488685]
SMMC-7721 IC50
>128 3
Compound: OdDHL
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
[PMID: 25707012]
MCF7 IC50
26.24 3
Compound: OdDHL
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 30553142]
MCF7 IC50
37.31 3
Compound: OdDHL
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
101.83 3
Compound: OdDHL
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
Cytotoxicity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 25707012]
MGC-803 IC50
29.53 3
Compound: OdDHL
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
Antiproliferative activity against human MGC803 cells after 72 hrs by MTT assay
[PMID: 30553142]
NCI-H630 IC50
12 3
Compound: OdDHL
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against 5FU-resistant human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
NCI-H630 IC50
34 3
Compound: OdDHL
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
Cytotoxicity against human NCI-H630 cells after 5 days by SRB assay
[PMID: 19260689]
PC-3 IC50
22.51 3
Compound: OdDHL
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
Antiproliferative activity against human PC3 cells after 72 hrs by MTT assay
[PMID: 30553142]
PC-3 IC50
5 3
Compound: OdDHL
Cytotoxicity against human PC3 cells after 5 days by SRB assay
Cytotoxicity against human PC3 cells after 5 days by SRB assay
[PMID: 19260689]
SMMC-7721 IC50
> 128 3
Compound: OdDHL
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
Cytotoxicity against human SMMC7721 cells after 72 hrs by MTT assay
[PMID: 25707012]
体外実験

N-3-oxo-dodecanoyl-L-homoserine lactone (25-100 μM, 18 h) inhibits the expression of IL-8 in cell L828, and induces chemotaxic of neutrophils through activation of NF-κB and ERK1/2[3].
N-3-oxo-dodecanoyl-L-homoserine lactone (50 μM, 24 h) induces ER stress response, ROS generation and decreased mitochondrial membrane potential, which causes the activation of caspase 3/8/9/12, thereby leading to apoptosis in BMDMs[6].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis[6]

Cell Line: BMDM
Concentration: 0-50 μM
Incubation Time: 24 h
Result: Induced apoptosis in BMDMs.

Western Blot Analysis[6]

Cell Line: BMDM
Concentration: 0-50 μM
Incubation Time: 1 h
Result: Increased cleaved caspase 3/8/9/12.
体内実験

N-3-oxo-dodecanoyl-L-homoserine lactone (0.3-1 mg/kg, ip, single dose) enhances immune bias of the host animal, exhibits immunomodulatory activity in OVA-immunized mouse models, ameliorates type 1 diabetes by inhibiting the activation and differentiation of naive T cells[4][5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: OVA-immunized mouse models[4]
Dosage: 0.3 mg/kg
Administration: ip, single dose
Result: Increased OVA-specific IgG1 (Th2-related antibody).
分子量

297.39

分子式

C16H27NO4

CAS 番号
Appearance

Solid

Color

White to light yellow

SMILES

CCCCCCCCCC(CC(N[C@@H]1C(OCC1)=O)=O)=O

輸送条件

Room temperature in continental US; may vary elsewhere.

保管条件

4°C, protect from light

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶剤 & 溶解度
体外: 

DMSO : 100 mg/mL (336.26 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

H2O : < 0.1 mg/mL (insoluble)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.3626 mL 16.8129 mL 33.6259 mL
5 mM 0.6725 mL 3.3626 mL 6.7252 mL
10 mM 0.3363 mL 1.6813 mL 3.3626 mL
View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

  • Molarity Calculator

  • Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始)

C1

×
体積 (開始)

V1

=
濃度 (終了)

C2

×
体積 (終了)

V2

体内:

Select the appropriate dissolution method based on your experimental animal and administration route.

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for in vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

  • Protocol 1

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (8.41 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

    Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
  • Protocol 2

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.41 mM); Clear solution

    This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

    Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

    Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

g

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
%
DMSO +
+
%
Tween-80 +
%
Saline
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Calculation results:
Working solution concentration: mg/mL
Method for preparing stock solution: mg drug dissolved in μL  DMSO (Stock solution concentration: mg/mL).

*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

The concentration of the stock solution you require exceeds the measured solubility. The following solution is for reference only. If necessary, please contact MedChemExpress (MCE).
Method for preparing in vivo working solution for animal experiments: Take μL DMSO stock solution, add μL . μL , mix evenly, next add μL Tween 80, mix evenly, then add μL Saline.
 If the continuous dosing period exceeds half a month, please choose this protocol carefully.
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
純度とドキュメンテーション

純度: 99.88%

参考文献

Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent Concentration Solvent Mass 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.3626 mL 16.8129 mL 33.6259 mL 84.0647 mL
5 mM 0.6725 mL 3.3626 mL 6.7252 mL 16.8129 mL
10 mM 0.3363 mL 1.6813 mL 3.3626 mL 8.4065 mL
15 mM 0.2242 mL 1.1209 mL 2.2417 mL 5.6043 mL
20 mM 0.1681 mL 0.8406 mL 1.6813 mL 4.2032 mL
25 mM 0.1345 mL 0.6725 mL 1.3450 mL 3.3626 mL
30 mM 0.1121 mL 0.5604 mL 1.1209 mL 2.8022 mL
40 mM 0.0841 mL 0.4203 mL 0.8406 mL 2.1016 mL
50 mM 0.0673 mL 0.3363 mL 0.6725 mL 1.6813 mL
60 mM 0.0560 mL 0.2802 mL 0.5604 mL 1.4011 mL
80 mM 0.0420 mL 0.2102 mL 0.4203 mL 1.0508 mL
100 mM 0.0336 mL 0.1681 mL 0.3363 mL 0.8406 mL
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質量   濃度   体積   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

一般には略語で表示されます:C1V1 = C2V2

濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

最近チェックした製品:

オンラインお問い合わせ

Your information is safe with us. * Required Fields.

製品名

 

カスタマ需要量 *

お名前 *

 

タイトル

メールアドレス *

 

電話番号 *

デパートメント

 

組纖名 *

市区町村

都道府県

国或いは地域 *

     

必ず会社名を記載ください。個人への返信は行いません。

備考

バルクお問い合わせ

Inquiry Information

製品名:
N-3-oxo-dodecanoyl-L-homoserine lactone
製品番号:
HY-114544A
数量:
MCE 日本正規代理店: